Point72 Hong Kong’s CureVac CVAC Stock Holding History

Point72 Hong Kong’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-15,752	Closed	-$214K	–	2009
2022 Q2	$214K	Buy	15,752 +14,720	+1,426%	+$244K	0.01%	964
2022 Q1	$20K	Buy	+1,032	New	+$20.6K	﹤0.01%	1523
2021 Q3	–	Sell	-526	Closed	-$39K	–	2057
2021 Q2	$39K	Buy	+526	New	+$52.6K	﹤0.01%	1521

Other funds holding CVAC

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 Hong Kong's CVAC Position: Q3 2022 in Review

Point72 Hong Kong sold out of CureVac (CVAC) in Q3 2022, closing a stake of 15,752 shares — an estimated $214K sold.

Point72 Hong Kong first reported a position in CVAC in Q2 2021 and held it in 3 quarters. The position peaked at $214K in Q2 2022. 83 funds tracked by Wall St. Rank hold CVAC as of Q3 2022.

Point72 Hong Kong reported no remaining CureVac position as of Q3 2022 after selling out during the quarter.
Point72 Hong Kong sold 15,752 CureVac shares in Q3 2022, an estimated $214K.
Point72 Hong Kong first reported a position in CureVac in Q2 2021 and held it in 3 quarters.
Point72 Hong Kong's CureVac position peaked at $214K in Q2 2022.
83 funds tracked by Wall St. Rank held CureVac as of Q3 2022.

Based on Point72 Hong Kong's 13F filing for Q3 2022, filed 14 Nov 2022.